Infinity Pharmaceuticals, Inc. - Neraca (Quarterly)

Infinity Pharmaceuticals, Inc.
DE ˙ DUSE ˙ US45665G3039
€ 0.02 ↑0.00 (3.64%)
2023-09-22
BAHAGING PRESYO
Talaan ng Balanse (Quarterly)

Neraca Infinity Pharmaceuticals, Inc. menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
Cash 19 29 107 97 90 81 53 46 47 38 26 18
Change (%) 54.32 273.36 -8.90 -7.37 -10.39 -34.19 -13.72 2.93 -18.80 -32.82 -31.05
Assets Current 43 36 109 100 92 82 70 60 49 40 28 20
Change (%) -17.15 203.46 -8.81 -7.78 -10.51 -14.79 -14.96 -17.21 -18.33 -29.62 -29.81
Assets 47 39 112 103 95 85 73 62 52 42 30 21
Change (%) -16.28 185.86 -8.72 -7.78 -10.39 -14.40 -14.77 -16.60 -18.30 -28.94 -29.11
Liabilities 61 62 60 61 62 63 63 63 62 61 58 59
Change (%) 1.99 -3.14 1.17 2.31 1.19 -0.98 0.59 -0.79 -2.02 -4.79 0.63
Equity -14 -23 52 42 32 22 10 -1 -11 -19 -28 -37
Change (%) 62.73 -326.40 -20.19 -22.62 -32.89 -53.72 -111.09 882.29 75.20 48.66 32.07
Liabilities And Stock Equity 47 39 112 103 95 85 73 62 52 42 30 21
Change (%) -16.28 185.86 -8.72 -7.78 -10.39 -14.40 -14.77 -16.60 -18.30 -28.94 -29.11

Source: Capital IQ

Other Listings
US:INFIQ
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista